Tai Sandi See - Feb 19, 2025 Form 4 Insider Report for Lexeo Therapeutics, Inc. (LXEO)

Role
Chief Development Officer
Signature
/s/ Youjin Choi, Attorney-in-Fact
Stock symbol
LXEO
Transactions as of
Feb 19, 2025
Transactions value $
-$6,558
Form type
4
Date filed
2/21/2025, 05:09 PM
Previous filing
Jan 10, 2025
Next filing
Apr 9, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXEO Common Stock Sale -$6.56K -1.49K -2.68% $4.41 53.9K Feb 19, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
F2 Includes 51,218 RSUs.